2025
SJR Q1
JCR Q1 · 8,1
157 eşleşen makale
SCIE
Dergi ayrıntısı
Phytotherapy Research
- Yayıncı
- John Wiley and Sons Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0951418X10991573
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,642
- Quartile Q1
- H-Index 177
- Atıf/yayın 8,5
- Doküman (3y) 983
- Atıf (3y) 8.782
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 8,1
- 5Y JIF 7,9
- JCI 1,41
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Pharmacology Q1
Alanlar
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Chemistry, Medicinal | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,642 | 8,1 | 7,9 | 1,41 | Q1 | 177 |
| 2024 | Q1 | Q1 | 1,477 | 6,3 | 7 | 1,34 | Q1 | 169 |
| 2023 | Q1 | Q1 | 1,277 | 6,1 | 7 | 1,25 | Q1 | 169 |
| 2022 | Q1 | Q1 | 1,073 | 7,2 | 6,8 | 1,27 | Q1 | 169 |
| 2021 | Q1 | Q1 | 1,046 | 6,4 | 6,3 | 1,23 | Q1 | 169 |
| 2020 | Q2 | Q1 | 1,019 | 5,9 | 5,3 | 1,33 | Q1 | 169 |
| 2019 | Q2 | Q1 | 0,905 | 4,1 | 4 | 1,24 | Q1 | 169 |
| 2018 | — | Q1 | — | 3,8 | 3,4 | 1,07 | Q1 | — |
| 2017 | Q1 | Q2 | 1,136 | 3,3 | 3,1 | 1,12 | Q1 | 169 |
| 2016 | Q2 | Q2 | 1,016 | 3,1 | 2,7 | — | — | 169 |
| 2015 | Q2 | Q2 | 0,85 | 2,7 | 2,5 | — | — | 169 |
| 2014 | Q2 | Q2 | 0,94 | 2,7 | 2,5 | — | — | 169 |
| 2013 | Q2 | Q2 | 0,83 | 2,4 | 2,5 | — | — | 169 |
| 2012 | Q2 | Q3 | 0,807 | 2,1 | 2,4 | — | — | 169 |
| 2011 | Q2 | Q3 | 0,794 | 2,1 | 2,5 | — | — | 169 |
| 2010 | Q2 | Q2 | 0,735 | 1,9 | 2,2 | — | — | 169 |
| 2009 | — | Q3 | — | 1,7 | 2 | — | — | — |
| 2008 | — | Q3 | — | 1,8 | 1,9 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,7 | — | — | — |
| 2006 | — | Q3 | — | 1,1 | — | — | — | — |
| 2005 | — | Q3 | — | 1,2 | — | — | — | — |
| 2004 | — | Q3 | — | 1 | — | — | — | — |
| 2003 | — | Q3 | — | 0,8 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q4 | — | 0,6 | — | — | — | — |
| 2000 | — | Q4 | — | 0,4 | — | — | — | — |
| 1999 | — | Q4 | — | 0,4 | — | — | — | — |
| 1998 | — | Q4 | — | 0,5 | — | — | — | — |
| 1997 | — | Q4 | — | 0,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 7/72 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 22/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 9/72 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 30/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 7/72 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 26/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 5/60 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 25/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 8/63 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 43/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 8/62 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 36/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 15/61 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 58/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q1 | 16/61 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 61/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q1 | 19/59 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 73/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 19/60 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 81/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 28/59 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 95/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 25/59 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 105/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 29/58 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 119/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 33/59 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 145/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 32/59 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 135/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 25/54 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 148/252 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 25/46 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 153/237 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 22/41 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/219 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 22/41 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 140/205 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 24/35 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 148/199 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 23/34 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 140/193 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 26/36 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 144/187 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 27/37 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 146/185 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 26/35 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/188 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 31/36 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 157/186 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 32/35 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 166/181 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 29/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 163/175 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 26/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 145/178 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 24/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 132/157 |